Bing

SEARCH HISTORY

Mitchell Gold, President and CEO of Dendreon Corporation (DNDN), will visit NASDAQ MarketSite in Times Square and preside over the NASDAQ Opening Bell. The Opening Bell is available from 9:20 a.m. to 9:35 a.m. on Galaxy 19 C/15, downlink …
GlobeNewswire · 5/27/2010
They have a price target of $66 on the stock. Meanwhile, other biotech stocks: GENZ, GILD, BIIB, AMGN all are up on a down market day, although HGSI is also experiencing a selloff. (Disclosure: long shares of DNDN but I daytrade it regularly.)
The Wall Street Journal · ByJames Altucher · 6/24/2010
Stepping back, the stock now sits at a year-to-date loss of 37.8%. Meanwhile, calls remain the options of choice in DNDN's options pits. The stock's Schaeffer's put/call open interest ratio (SOIR) of 0.50 ranks higher than just 22% of other such readings ...
Minyanville · 8/23/2013
Dendreon Corporation (DNDN) was one of the Russell 2000's biggest losers for August 12 as the stock slid 33.96% to $1.40, a loss of $0.72 per share. Starting at an opening price of $1.67 a share, the stock traded between $1.33 and $1.73 over the course of ...
Stockhouse · 8/13/2014
Dendreon Corporation (NASDAQ:DNDN) was the most active in the industry, adding 6.80% to close at $6.91 after analyst actions. Sanford C. Bernstein analysts upgraded and lifted their PT on the stock claiming that Provenge is projected to have a 10% to …
The Real Edge Magazine · 2/11/2013
Benzinga has identified 6 names that are up over 50% already ... as investors recalibrate their expectations for 2012 Provenge revenue. So far this month, DNDN's stock has risen 93% and it is possible that it could see more gains. Prior to last August's ...
Benzinga · ByScott Rubin · 1/27/2012
A large number of biotech stocks have been clearing healthy bases recently. While each stock has an individual story related to a drug or product, their strong performance as a group shows that investors have been willing to put money to work in riskier ...
Investopedia · 3/8/2010
Commentary was issued on the stock yesterday on its participation in the anti obesity market. Dendreon Corp. (NasdaqGS DNDN) is trading at $6.66, up 0.41(6.56%) 11:11AM EDT, with a high of $6.98 on volume of over 8 million shares. Horizon Pharma ...
investorideas.com · 6/13/2012
DNDN is trading up 0.75% at $5.38 on Thursday. The stock has been trading between $3.69 and $17.04 for the past 52 weeks. Hampton Roads Bankshares (HMPR) Names Interim Finance Chief Apollo Group (APOL) Unit Receives Contract From Advanced …
istock Analyst · 12/20/2012
A small biotech company, Dendreon (DNDN), made a big splash last week when it released positive data for its prostate cancer vaccine Provenge. In a nano-second, Dendreon went from obscurity to savior. Investors holding Dendreon stock suddenly found ...
Wealth Daily · ByBrian Hicks · 4/22/2009